Home › Funds › Voss Capital, LP › RNTX
Voss Capital, LP position in RNTX
REIN THERAPEUTICS INC · Health Care
Voss Capital, LP reported holding 5,261,921 shares of RNTX (REIN THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$5.5M, representing 0.38% of its reported portfolio and ranking #32 among its reported holdings. Voss Capital, LP has disclosed RNTX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Voss Capital, LP's RNTX position evolved
Voss Capital, LP first disclosed a stake in RNTX in Q4 2024 at 956,195 shares (US$2.2M). The position peaked in Q1 2026 at 4,388,362 shares, worth US$5.7M. Across 7 filings, Voss Capital, LP increased the stake 6 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 5,261,921 shares valued at US$5.5M — an increase of 873,559 shares quarter over quarter.. Notable position changes include a 45% increase in Q2 2025 (shares fell 18% over the following quarter), a 86% increase in Q3 2025 (shares rose 1% over the following quarter), a 59% increase in Q4 2025 (shares rose 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 956.20K | $2.20M | New |
| Q1 2025 | 990.72K | $1.75M | Add |
| Q2 2025 | 1.43M | $2.01M | Add |
| Q3 2025 | 2.67M | $3.05M | Add |
| Q4 2025 | 4.24M | $4.92M | Add |
| Q1 2026 | 4.39M | $5.70M | Add |
| Q2 2026 | 5.26M | $5.47M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RNTX and 13F data
RNTX (REIN THERAPEUTICS INC) is a Health Care company. 54 other funds we track also report a position in RNTX — the largest reported positions include Cable Car Capital, LP (US$5.4M), BIOS Capital Management, LP (US$3.1M), GREAT POINT PARTNERS LLC (US$2.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RNTX
- Cable Car Capital, LP 5.20M sh · $5.40M · Q2 2026
- BIOS Capital Management, LP 2.98M sh · $3.10M · Q2 2026
- GREAT POINT PARTNERS LLC 2.58M sh · $2.68M · Q2 2026
- Velan Capital Investment Management LP 1.70M sh · $1.77M · Q2 2026
- Prosight Management, LP 1.10M sh · $1.14M · Q2 2026
- Bleichroeder LP 1.00M sh · $1.04M · Q2 2026
- Empery Asset Management, LP 370.83K sh · $385.67K · Q2 2026
More on Voss Capital, LP
FAQ
How long has Voss Capital, LP held RNTX?
Voss Capital, LP has disclosed RNTX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is Voss Capital, LP's current position in RNTX?
As of Q2 2026, Voss Capital, LP holds 5.26M shares of RNTX (REIN THERAPEUTICS INC), valued at $5.47M, representing 0.38% of its reported portfolio and ranking #32.
Has Voss Capital, LP been buying or selling RNTX?
In the latest 13F filing (Q2 2026), Voss Capital, LP increased its position in RNTX. The position peaked in Q1 2026 at 4.39M shares.
Which other funds hold RNTX?
Other major institutional holders of RNTX include Cable Car Capital, LP, BIOS Capital Management, LP, GREAT POINT PARTNERS LLC, among 54 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.